The report will be delivered in 2-3 business days.

Influenza Diagnostic Market Global Report 2020-30: Covid 19 Implications And Growth

Starting Price : $ 4000.00 | Pages : 150 | Published : July 2020 | SKU CODE : 7561 | Format :


The influenza diagnostic market consists of sales of diagnostic tests used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting the diagnostics tests for influenza virus detection.

The global influenza diagnostics market is expected to grow from $1.14 billion in 2019 to 1.31 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%. A significant increase is registered in 2020 due to the COVID 19 outbreak. The global pandemic which is expected to be there for some time and the upcoming flu season could place a tremendous burden on the healthcare system and result in many illnesses, hospitalizations and deaths. This is expected to drive the demand for more rapid detection diagnostic kits. Since COVID-19 and the flu are respiratory illnesses and can cause similar symptoms, the governments across the globe are making preparedness plans. For instance, the CDC is seeking emergency use authorization from the FDA for a new assay that can simultaneously detect SARS-CoV-2 and influenza. The market is then expected to stabilize and reach $1.43 billion in 2023 at a CAGR of 2.89%.

North America was the largest region in the global influenza diagnostics market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

 

The major factor driving the market is increasing funding for research on influenza diagnostics. Addressing the public health impact of influenza disease requires a proper understanding of the virus and its effect on individuals and populations. Therefore, it is important to accelerate the pace of scientific research progress that can have the greatest public health impact. Many public and private health organizations, researchers, health professionals, biopharmaceutical companies have maximized the spending for research funds or grants to reduce the risk of the emergence of pandemic influenza. For instance, in 2019, the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, a new network of research centers that will work together to develop influenza vaccines. NIAID will provide up to approximately $51 million in total first-year funding for the program, which is designed to support the CIVICs program centers over seven years.

The variability in sensitivity and specificity among the influenza diagnostic tests is restraining the growth of the market. In most rapid flu tests, there are difficulties in identifying patients with influenza. The sensitivity of rapid flu tests ranges from 10-80% across various patient populations. Most diagnostic tests show an increase in the rate of false-negative results during low influenza virus activity, which often leads to an incorrect diagnosis. Thus, the variability in sensitivity and specificity is restraining the growth of the influenza diagnostic market.

Rapid influenza diagnostic tests (RIDTs) are increasingly being implemented in influenza diagnostics. RIDTs are immunoassays which can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and display the result in a qualitative way (positive vs. negative). It can yield results in a clinically relevant time frame of less than approximately 15 minutes and diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms. The rising popularity of RIDT is due to the benefits such as simple to use and rapid diagnosis.

In June 2019, Meridian Bioscience Inc., an international producer and distributor of a range of diagnostic test kits, completed its acquisition of GenePoc Inc., a Canadian provider of molecular diagnostic instruments and assays. Meridian will now include GenePOC’s state-of-the-art revogene molecular diagnostics platform, which offers samples to result in testing for single tests, as well as flexible multiplexing capability. GenePOC is a subsidiary of Debiopharm Group. It specializes in the development and commercialization of rapid molecular assays usable on the unique revogene platform for near-patient infectious disease diagnostic.

In 2018, Siemens Healthineers acquired Fast Track Diagnostics for an undisclosed amount. By introducing Fast Track Diagnostics products to its molecular diagnostics portfolio, Siemens Healthineers is investing in precision medicine and better patient experience through solutions that eliminate the need for repeat diagnostic testing, reducing time and improving patient outcomes. Fast Track Diagnostics specializes in the design, development and manufacture of infectious disease detection kits that use syndromic multiplex real-time PCR.

Major players in the market are F. Hoffmann-La Roche Ltd, Quidel Corporation, ?h?rm? F??h?r, Abbott Laboratories, Hologic, Becton, Dickinson and Company, DiaSorin S.p.A., Luminex Corporation, Meridian Bioscience, Inc., GenMark Diagnostics.

The countries covered in the influenza diagnostic global market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

The influenza diagnostic global market report is segmented: 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Othes 2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests 3) By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    1. Executive Summary

    2. Influenza Diagnostics Market Characteristics

    3. Influenza Diagnostics Market Size And Growth

    3.1. Global Influenza Diagnostics Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Influenza Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Influenza Diagnostics Market Segmentation

    4.1. Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Rapid influenza diagnostic tests (RIDT)

    Viral Culture

    DFA

    Serological assays

    Othes

    4.2. Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Reverse Transcription Polymerase Chain Reaction (RT-PCR)

    Isothermal Nucleic Acid Amplification Tests (INAAT)

    Loop Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Transcription Mediated Isothermal Based Amplification Assays

    Other Isothermal Nucleic Acid Amplification Tests

    Other Molecular Diagnostic Tests

    4.3. Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospitals & Clinical Laboratories

    Diagnostic Reference Laboratories

    Academic/Research Institutes

    Other End Users

    5. Influenza Diagnostics Market Regional And Country Analysis

    5.1. Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Influenza Diagnostics Market

    6.1. Asia-Pacific Influenza Diagnostics Market Overview

    6.2. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Influenza Diagnostics Market

    7.1. China Influenza Diagnostics Market Overview

    7.2. China Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    7.3. China Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Influenza Diagnostics Market

    8.1. India Influenza Diagnostics Market Overview

    8.2. India Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    8.3. India Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Influenza Diagnostics Market

    9.1. Japan Influenza Diagnostics Market Overview

    9.2. Japan Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9.3. Japan Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Influenza Diagnostics Market

    10.1. Australia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10.2. Australia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Influenza Diagnostics Market

    11.1. Indonesia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11.2. Indonesia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Influenza Diagnostics Market

    12.1. South Korea Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12.2. South Korea Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Influenza Diagnostics Market

    13.1. Western Europe Influenza Diagnostics Market Overview

    13.2. Western Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13.3. Western Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Influenza Diagnostics Market

    14.1. UK Influenza Diagnostics Market Overview

    14.2. UK Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14.3. UK Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Influenza Diagnostics Market

    15.1. Germany Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15.2. Germany Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Influenza Diagnostics Market

    16.4. France Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16.5. France Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Influenza Diagnostics Market

    17.1. Eastern Europe Influenza Diagnostics Market Overview

    17.2. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Influenza Diagnostics Market

    18.1. Russia Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18.2. Russia Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Influenza Diagnostics Market

    19.1. North America Influenza Diagnostics Market Overview

    19.2. North America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19.3. North America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Influenza Diagnostics Market

    20.1. USA Influenza Diagnostics Market Overview

    20.2. USA Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20.3. USA Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Influenza Diagnostics Market

    21.1. South America Influenza Diagnostics Market Overview

    21.2. South America Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21.3. South America Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Influenza Diagnostics Market

    22.1. Brazil Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22.2. Brazil Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Influenza Diagnostics Market

    23.1. Middle East Influenza Diagnostics Market Overview

    23.2. Middle East Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23.3. Middle East Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Influenza Diagnostics Market

    24.1. Africa Influenza Diagnostics Market Overview

    24.2. Africa Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24.3. Africa Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Influenza Diagnostics Market Competitive Landscape And Company Profiles

    25.1. Influenza Diagnostics Market Competitive Landscape

    25.2. Influenza Diagnostics Market Company Profiles

    25.2.1. F. Hoffmann-La Roche Ltd

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Quidel Corporation

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. ?h?rm? F??h?r

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Abbott Laboratories

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Hologic

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Influenza Diagnostics Market

    27. Influenza Diagnostics Market Trends And Strategies

    28. Influenza Diagnostics Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 47: Quidel Corporation Financial Performance
  • Table 48: ?h?rm? F??h?r Financial Performance
  • Table 49: Abbott Laboratories Financial Performance
  • Table 50: Hologic Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Influenza Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Influenza Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Influenza Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: China, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: China, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: India, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: India, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Japan, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: Japan, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Australia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: Australia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: South Korea, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: South Korea, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: UK, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: UK, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Germany, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 27: Germany, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 28: France, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 29: France, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 32: Russia, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 33: Russia, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 34: North America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 35: North America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 36: USA, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 37: USA, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 38: South America, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 39: South America, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 40: Brazil, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 41: Brazil, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 42: Middle East, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 43: Middle East, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 44: Africa, Influenza Diagnostics Market, Segmentation By Traditional diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 45: Africa, Influenza Diagnostics Market, Segmentation By Molecular diagnostic tests, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 46: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 47: Quidel Corporation Financial Performance
  • Figure 48: ?h?rm? F??h?r Financial Performance
  • Figure 49: Abbott Laboratories Financial Performance
  • Figure 50: Hologic Financial Performance
Demand For Corticosteroids Therapy Has Grown Due To Positive Outcomes In Treatment Of Covid-19
The Respiratory Devices Market Will See Significant Growth As Covid-19 Cases Rise
The N95 And Surgical Masks Market Is Experiencing An Exponential Growth Due To The Covid-19 Pandemic
Asia Pacific Was The Largest Region Accounting For 37% Of The Global Diagnostic Imaging Centers Market
The Microneedle Drug Delivery System Is Gaining Popularity In The Drug Delivery Devices Market
Use Of Combination Drugs For Antiretroviral Therapy In The HIV Drugs Market
Rapidly Aging Population Will Significantly Affect The Retirement Communities Market Growth
Adoption Of Cognitive Behavioral Therapy And Applied Behavioral Analysis In The Psychiatrists’ Market
Community Oncology Services Global Market Report 2020-30: Covid 19 Growth and Change
View Report
Fertility Services Global Market Report 2020-30: Covid 19 Growth and Change
View Report
Robotic Surgery Services Market Global Report 2020-30: Covid 19 Growth and Change
View Report
Retirement Communities Market - By Type (Continuing Care Retirement Communities, Rest Homes, Assisted Living Facilities, Assisted Living Facilities With Nursing Care), By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Psychiatrists Market - By Type (Mental Disorder Type, Patient Type, Geography), Drivers, Restraints, And Major Players, By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Truck Transportation Global Market Report 2020
View Report
Dimension Stone Mining Global Market Report 2020
View Report
Crushed Stone Mining Global Market Report 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)